文献詳細
特集 一般医家のための—DOAC時代の心房細動診療
心房細動の病態と診断
文献概要
Point
◎心房細動と診断されれば経胸壁心エコーを行う.
◎CHADS2スコアで抗凝固療法の適応とならなくても,左房径拡大(>45 mm)や左室肥大があれば抗凝固療法を検討する.
◎心房細動と診断されれば,肝・腎機能,甲状腺機能,血算,電解質に加えて,NT-proBNP(BNP)の測定も行う.
◎NT-proBNP高値であれば,死亡,心不全入院だけでなく,脳卒中/全身塞栓症を起こす可能性も高い.
◎心房細動と診断されれば経胸壁心エコーを行う.
◎CHADS2スコアで抗凝固療法の適応とならなくても,左房径拡大(>45 mm)や左室肥大があれば抗凝固療法を検討する.
◎心房細動と診断されれば,肝・腎機能,甲状腺機能,血算,電解質に加えて,NT-proBNP(BNP)の測定も行う.
◎NT-proBNP高値であれば,死亡,心不全入院だけでなく,脳卒中/全身塞栓症を起こす可能性も高い.
参考文献
1)Ono K, et al:JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias. Circ J 86:1790-1924, 2022
2)Hamatani Y, et al:Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep 6:31042, 2016
3)Cabin HS, et al:Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 65:1112-1116, 1990
4)Yamamoto K, et al:The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 25:1634-1640, 1995
5)Tomita F, et al:Prevalence and clinical characteristics of patients with atrial fibrillation;Analysis of 20,000 cases in Japan. Jpn Circ J 64:653-658, 2000
6)Kitaoka H, et al:JCS/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies. Circ J 85:1590-1689, 2021
7)Tezuka Y, et al:Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation;The Fushimi AF Registry. Eur Hear J Qual Care Clin Outcomes 6:273-283, 2020
8)Kitaoka H, et al:JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J 84:1610-1671, 2020
9)Galderisi M, et al:Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging 19:245-252, 2018
10)Hamatani Y, et al:Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure. Heart 107:705-712, 2021
11)Goetze JP, et al:Atrial secretion of B-type natriuretic peptide. Eur Heart J 27:1648-1650, 2006
12)Berg DD, et al:Performance of the ABC scores for assessing the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48. Circulation 139:760-771, 2019
13)Niederdöckl J, et al:The ABC-stroke score refines stroke risk stratification in patients with atrial fibrillation at the emergency department. Front Med 9:830580, 2022
掲載誌情報